Skip to content

Advertisement

Open Peer Review Reports for: Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
20 Sep 2016 Submitted Original manuscript
17 Mar 2017 Reviewed Reviewer Report - Joan Lewis-Wambi
8 May 2017 Reviewed Reviewer Report - Hamidreza Montazeri Aliabadi
9 May 2017 Reviewed Reviewer Report - Andreja Ambriovic-Ristov
29 Jun 2017 Author responded Author comments - Katharina Gohr
Resubmission - Version 2
29 Jun 2017 Submitted Manuscript version 2
10 Aug 2017 Reviewed Reviewer Report - Andreja Ambriovic-Ristov
26 Sep 2017 Author responded Author comments - Katharina Gohr
Resubmission - Version 3
26 Sep 2017 Submitted Manuscript version 3
Publishing
19 Oct 2017 Editorially accepted
3 Nov 2017 Article published 10.1186/s12885-017-3695-5

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement